DDX3X Syndrome: Clinical, Neuroimaging, AI-Assisted Facial Profiling and Genotype–Phenotype Correlations
Genes · 05.05.2026 · 17 (5) · 551
DOI: 10.3390/genes17050551 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Genes, online erschienen am 05.05.2026. Verfasst von Sara Hadj Sadok und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Hospital Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain. Hauptthemen laut MEDLINE: DEAD-box RNA Helicases, Intellectual Disability. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: DDX3X syndrome (MIM#300958) is a neurodevelopmental disorder associated with intellectual disability, language impairment, and a characteristic neurobehavioral phenotype that predominantly affects females. Although dysmorphic features have been reported, a consistent facial phenotype and clear genotype–phenotype correlations have not been established.
Methods
We conducted an observational, ambispective, descriptive study including patients aged 0–18 years with a molecular diagnosis of DDX3X. Clinical, standardized facial images, neurobehavioral, neuroimaging, and molecular data were collected. Automated facial analysis was performed using Face2Gene after algorithm training.
Results
Of 11 identified patients, 9 were included (8 females); 8 variants were de novo and 4 novel. Two variants of uncertain significance underwent in silico analysis. Frequent facial features included thin upper lip (9/9), tapered chin (8/9), long uniform eyebrows (8/9), short neck (8/9), and long face (6/9). After training, Face2Gene identified DDX3X syndrome in 92% of cases within the top 5 suggestions, supporting its utility as a diagnostic aid. All females had intellectual disability and language disorder; 66% presented sleep disturbances and aggressive behavior. Neuroimaging revealed ventricular dilatation (5/9) and corpus callosum hypoplasia (3/9). Loss-of-function variants were associated with greater clinical severity.
Conclusions
This series suggests a recognizable facial phenotype of DDX3X syndrome and supports a possible genotype–phenotype correlation. Further studies are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Hospital Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain.
- Center for Genomic Medicine, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08193 Sabadell, Spain.
- Institut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras, 28029 Madrid, Spain.
- Departament of Medical Genetics, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 El Palmar Murcia, Spain.
ORCID-Profile: Alicia Irene Serra, Leticia Diana Pias-Peleteiro, Judith Armstrong, Antonio F Martínez-Monseny
Zitieren
APA
Sadok, S. H., Serra, A. I., Pias-Peleteiro, L. D., Chaparro, D. S., Xiol, C., Armstrong, J., Guillén-Navarro, E., & Martínez-Monseny, A. F. (2026). DDX3X Syndrome: Clinical, Neuroimaging, AI-Assisted Facial Profiling and Genotype–Phenotype Correlations. Genes, 17(5), 551. https://doi.org/10.3390/genes17050551
Vancouver
Sadok SH, Serra AI, Pias-Peleteiro LD, Chaparro DS, Xiol C, Armstrong J, et al. DDX3X Syndrome: Clinical, Neuroimaging, AI-Assisted Facial Profiling and Genotype–Phenotype Correlations. Genes. 2026;17(5):551. doi:10.3390/genes17050551
BibTeX
@article{Sadok2026,
author = {Sadok, Sara Hadj and Serra, Alicia Irene and Pias-Peleteiro, Leticia Diana and Chaparro, Diana Salinas and Xiol, Clara and Armstrong, Judith and Guillén-Navarro, Encarna and Martínez-Monseny, Antonio F},
title = {DDX3X Syndrome: Clinical, Neuroimaging, AI-Assisted Facial Profiling and Genotype–Phenotype Correlations},
journal = {Genes},
year = {2026},
volume = {17},
number = {5},
pages = {551},
doi = {10.3390/genes17050551}
}
EUVIMED